Shreekant Parasuraman

Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey

Ruben A. Mesa, Carole B. Miller, Maureen Thyne et al. · Cancer · 2016 · 91 citations · Full text

Medicine, Hematology, Oncology +17

Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017

Milind Javle, Sunyoung Lee, Nilofer S. Azad et al. · The Oncologist · 2022 · 84 citations · Full text

Medicine, Oncology, Cancer Epidemiology +13

Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation

Jingbo Yu, Shreekant Parasuraman, Anshul Shah et al. · Current Medical Research and Opinion · 2018 · 76 citations · Full text

Medicine, Hematology, Surgery +14

Glycemic Control and Risk of Cardiovascular Disease Hospitalization and All-Cause Mortality

Gregory A. Nichols, Sandra Joshua-Gotlib, Shreekant Parasuraman · Journal of the American College of Cardiology · 2013 · 70 citations

Medicine, Cardiology, Chronic Disease Control +14

Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: Results from a randomized, placebo‐controlled trial

Atul Deodhar, Jürgen Braun, Robert D. Inman et al. · Arthritis Care & Research · 2010 · 64 citations

Medicine, Internal Medicine, Pharmacotherapy +17